Clinical Trial

Cannabis' Impact on Alcohol Consumption

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo. The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-05-20; most recent amendment 2024-08-05.
Status change: Not Yet Recruiting → Recruiting 2023-03-20
Trial Details
NCT Number NCT05389930
Lead Sponsor Brown University
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions Alcohol Drinking, Cannabis Use, Cannabis, Alcohol Use Disorder
Enrollment 350 participants
Start Date 2023-03-16
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-06